Painful endometriosis?

If you are experiencing pain with endometriosis you may qualify for a clinical trial assessing the safety and effectiveness of an investigational drug.

One of the research priorities highlighted in the JLA Priority Setting Partnership, published in The Lancet, is to help advance the medical understanding about endometriosis.

If this is a priority for you too, and if you struggle with moderate to severe pain associated with endometriosis, you may be eligible to participate in the Edelweiss study.

What is the purpose of the Edelweiss study?

The Edelweiss study is assessing the safety and effectiveness of an investigational drug alone and in combination with hormonal add‑back therapy compared to placebo in women with moderate to severe pain associated with endometriosis.

Is study participation an option for me?

You may qualify to participate if you:

  • are 18 to 49 years old
  • have had a surgically confirmed diagnosis of endometriosis within the last 10 years
  • have endometriosis-associated pain during your period and at other times during your menstrual cycle
  • are not pregnant, breastfeeding, or planning to become pregnant
  • live in the USA or Canada

There are other requirements for participation in the studies that a study doctor and staff will explain to you in greater detail.

To learn more about the Edelweiss Study, eligibility criteria, and to see if you may qualify visit

See also

Stay up to date

Register for endometriosis news:


Recommend, read later, or share this article

Get involved

Help us improve treatments for endometriosis and prevent this disease in the next generation of women. Support the work of the World Endometriosis Research Foundation.

Donate to research Shop for WERF Volunteer